Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Tiopronin-induced reversible bilateral parotid gland enlargement in a patient with alcoholic cirrhosis: Case report.

Created on 15 Aug 2026

Authors

Shunshun Jiang, Ge Chen, Lingling Kong, Hong Zhao

Published in

Medicine. Volume 105. Issue 33. Pages e50001. Aug 14, 2026.

Abstract

Drug-induced parotid gland enlargement is uncommon, and reports associated with tiopronin are extremely rare in both domestic and international literature. The mechanism remains unclear, and its rapid onset may easily lead to misdiagnosis as allergic reactions or other salivary gland diseases. Timely recognition and management are crucial to avoid unnecessary interventions.
A 63-year-old man with alcoholic cirrhosis was admitted to our department for further management. Tiopronin was administered intravenously for hepatoprotective purposes. Approximately 20 minutes after the initiation of the infusion, the patient developed painless bilateral parotid gland swelling.
Emergency drug withdrawal was carried out immediately, and an ultrasound examination demonstrated bilateral parotid gland enlargement without obvious inflammatory changes or ductal dilation, consistent with acute noninflammatory sialadenosis.
The tiopronin infusion was discontinued promptly. No additional interventions were administered. The patient was monitored closely with serial physical examinations.
During the evening ward round on the same day, a significant reduction in parotid swelling was observed. Two days later, bilateral parotid gland enlargement had nearly completely resolved without specific treatment.
Tiopronin-induced acute parotid gland enlargement is extremely rare. This case highlights the importance of considering drug-induced sialadenosis as a differential diagnosis when acute parotid swelling occurs shortly after drug administration. Early identification and discontinuation of the suspected agent can lead to rapid resolution, avoiding unnecessary interventions. Clinicians should be aware of this potential reaction and strengthen pharmacovigilance during tiopronin use.

PMID:
42601754
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement